{
    "title": "Glaxo lures top scientist from Google by offering him up to \u00a31.6m more than their chief exec",
    "url": "https://www.dailymail.co.uk/money/markets/article-5063439/Glaxo-lures-scientist-Google.html",
    "date": "2017-11-08",
    "keywords": [
        "research",
        "share",
        "fund",
        "glaxosmithkline",
        "scientist",
        "hal",
        "barron",
        "officer",
        "cancer",
        "gsk",
        "investment",
        "account",
        "fee",
        "drugmaker",
        "google",
        "head",
        "boss",
        "emma",
        "walmsley",
        "home",
        "maximum",
        "report",
        "yearbarron",
        "calico",
        "ageing",
        "process",
        "alphabet",
        "pay",
        "rise",
        "dr",
        "headbefore",
        "pharma",
        "business",
        "roche",
        "genentech",
        "division",
        "drug",
        "giant",
        "consumer",
        "firm",
        "chief",
        "chairman",
        "ms",
        "admission",
        "article",
        "host",
        "medicine",
        "avastin",
        "appointment",
        "lead",
        "oncology",
        "coup",
        "walmsleybarron",
        "francisco",
        "hub",
        "stevenagehe",
        "base",
        "bonus",
        "plan",
        "end",
        "targetshe",
        "vallance",
        "year",
        "adviser",
        "cent",
        "diy",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}